Clinical Trial Update: Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the combination of pegylated interferon alfa-2b and ribavirin for chronic hepatitis B and hepatitis D.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis D

Drugs mentioned

• Pegylated Interferon Alfa-2b (pegylated interferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Chronic Hepatitis B, Chronic Hepatitis D | Phase 4 | Status: UNKNOWN